Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
61.84
+0.40 (0.64%)
Aug 31, 2026, 10:52 AM EDT - Market open
Inspire Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 898.74 | 911.98 | 802.8 | 624.8 | 407.86 | 233.39 | |
Revenue Growth | 4.35% | 13.60% | 28.49% | 53.19% | 74.75% | 102.28% |
Cost of Revenue | 124.64 | 133.23 | 122.99 | 96.58 | 66.12 | 33.28 |
Gross Profit | 774.11 | 778.76 | 679.82 | 528.22 | 341.74 | 200.12 |
Selling, General & Admin | 620.31 | 624.64 | 529.61 | 451.96 | 320.69 | 202.62 |
Research & Development | 99.68 | 103.17 | 114.13 | 116.54 | 68.65 | 37.35 |
Operating Expenses | 719.98 | 727.8 | 643.74 | 568.49 | 389.33 | 239.97 |
Operating Income | 54.12 | 50.95 | 36.08 | -40.27 | -47.59 | -39.85 |
Interest Expense | -0.14 | -0.14 | -0.02 | - | -1.68 | -2.13 |
Interest & Investment Income | 15.47 | 17.54 | 23.25 | 20.56 | 5.05 | 0.13 |
Currency Exchange Gain (Loss) | -1 | -1 | -0.9 | -0.2 | -0.1 | - |
Other Non Operating Income (Expenses) | -3.12 | -1.66 | 0.05 | 0.01 | 0.05 | -0.12 |
Pretax Income | 69.38 | 65.7 | 58.45 | -19.91 | -44.27 | -41.97 |
Income Tax Expense | -65.66 | -79.73 | 4.94 | 1.25 | 0.61 | 0.07 |
Net Income | 135.04 | 145.42 | 53.51 | -21.15 | -44.88 | -42.04 |
Net Income to Common | 135.04 | 145.42 | 53.51 | -21.15 | -44.88 | -42.04 |
Net Income Growth | 154.22% | 171.77% | - | - | - | - |
Shares Outstanding (Basic) | 29 | 29 | 30 | 29 | 28 | 27 |
Shares Outstanding (Diluted) | 29 | 30 | 31 | 29 | 28 | 27 |
Shares Change | -3.84% | -2.57% | 4.24% | 4.38% | 2.97% | 4.56% |
EPS (Basic) | 4.66 | 4.95 | 1.80 | -0.72 | -1.60 | -1.54 |
EPS (Diluted) | 4.61 | 4.89 | 1.75 | -0.72 | -1.60 | -1.54 |
EPS Growth | 164.44% | 179.43% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 117.09 | 78.48 | 91.12 | 1.02 | 2.47 | -24.79 |
Free Cash Flow Per Share | 3.99 | 2.64 | 2.98 | 0.04 | 0.09 | -0.91 |
Gross Margin | 86.13% | 85.39% | 84.68% | 84.54% | 83.79% | 85.74% |
Operating Margin | 6.02% | 5.59% | 4.50% | -6.44% | -11.67% | -17.07% |
Profit Margin | 15.03% | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% |
Free Cash Flow Margin | 13.03% | 8.61% | 11.35% | 0.16% | 0.61% | -10.62% |
EBITDA | 71.33 | 64.91 | 42.63 | -37.43 | -45.73 | -38.63 |
EBITDA Margin | 7.94% | 7.12% | 5.31% | -5.99% | -11.21% | -16.55% |
D&A For EBITDA | 17.21 | 13.96 | 6.55 | 2.85 | 1.86 | 1.22 |
EBIT | 54.12 | 50.95 | 36.08 | -40.27 | -47.59 | -39.85 |
EBIT Margin | 6.02% | 5.59% | 4.50% | -6.44% | -11.67% | -17.07% |
Effective Tax Rate | - | - | 8.46% | - | - | - |
Advertising Expenses | - | 114.9 | 94.9 | 100.3 | 74.3 | 47.8 |